キャスラボのアメリカ市場2020-2027:コンポーネント別(サービス(治療サービス、診断サービス)、機器)、施設種類別(個人研究所、病院系研究所)

◆英語タイトル:U.S. Cath Labs Market Size, Share & Trends Analysis Report By Component (Services (Therapeutic Services, Diagnostic Services), Equipment), By Facility Type (Independent Labs, Hospital Based Labs), And Segment Forecasts, 2020 - 2027
◆商品コード:GV20NV225
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年10月20日
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、キャスラボのアメリカ市場について調査・分析し、研究目的、エグゼクティブサマリー、市場要因・動向・範囲、コンポーネント別分析、施設種類別分析、競争状況、調査方法・範囲などを整理しました。
【レポートの概要】

U.S. Cath Labs Market Growth & Trends
The U.S. cath labs market size is expected to reach USD 24.3 billion by 2027, expanding at a CAGR of 5.3%, according to a new report by Grand View Research, Inc. The growing prevalence of cardiovascular diseases, the increasing number of coronary angiography performed each year, and the aging population prone to various heart problems, are the major factors driving the market. In addition, technological advancements and a growing preference for robot-assisted minimally invasive surgeries are other key factors propelling the growth of the market.

According to the American Heart Association (AHA), coronary artery disease affects 16.5 million Americans. The elective Percutaneous Coronary Intervention (PCI) is a commonly performed procedure in the U.S, with around 600,000 procedures performed each year. These procedures have the highest aggregate costs of all cardiovascular procedures, and PCI also has the third-highest aggregate cost of any surgical procedure, estimated at about USD 10.0 billion annually.

U.S. Cath Labs Market Report Highlights

• The services segment dominated the market in 2019, attributed to a large number of patients seeking advanced diagnostic and treatment options for various heart diseases

• With the technological advancements, and integration and technology collaboration between the cath laboratory and the equipment providers, the equipment segment is expected to witness significant growth during the forecast period

• The therapeutics segment dominated the market in 2019, owing to increased patient preference for cath laboratory interventions, shorter hospital stays, smaller incisions at the site of surgery that reduces the risk of infection, less blood loss and transfusions, and other benefits

• Stent placement dominated the therapeutic services segment in 2019 attributed to the growing annual incidence of Percutaneous Coronary Interventions (PCI) in the U.S.

• Cardiac catheterization dominated the diagnostic segment attributed to the rising incidence of arterial blockage cases due to an unhealthy lifestyle in the region

• Hospitals based cath laboratories have a major share owing to the patient flow and the increasing chronic and emergency case-patients. Moreover, better reimbursement available for the interventions performed at the hospitals is also driving the segment growth. Hospitals are revamping their existing cath labs and funding hybrid laboratories integration for treating multiple conditions under the same roof and for increased profitability

• Mergers and acquisitions and technology collaborations are the main strategies followed by market leaders.

【レポートの目次】

Table of Contents

Chapter 1 Research Objective
1.1 Objective – 1:
1.2 Objective – 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Component
2.2.2 Facility Type
2.3 Competitive Insights
2.4 U.S. Cath Labs Market Snapshot
Chapter 3 U.S. Cath Labs Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Market Segmentation
3.3 Penetration and Growth Prospect Mapping
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rising incidence of cardiovascular diseases
3.4.1.2 Low operational cost
3.4.1.3 Technological advancement
3.4.2 Market Restraint Analysis
3.4.2.1 Lack of reimbursement for independent labs
3.4.2.2 High maintenance cost for multispecialty labs
3.5 Business Environment Analysis Tools
3.5.1 Industry Analysis – Porter’s
3.5.1.1 Competitive rivalry
3.5.1.2 Threat of new entrants
3.5.1.3 Bargaining power of buyers
3.5.1.4 Bargaining power of suppliers
3.5.1.5 Threat of substitutes
3.5.2 PEST Analysis
3.5.2.1 Political Landscape
3.5.2.2 Economic and Social Landscape
3.5.2.3 Technology Landscape
3.6 Major Deals & Strategic Alliances Analysis
3.6.1 LICENSING & PARTNERSHIP
3.6.2 Mergers & Acquisitions
Chapter 4 U.S. Cath Labs Market: Component Estimates & Trend Analysis
4.1 Segment Dashboard
4.2 U.S. Cath Labs Market: Component Movement Analysis, USD Million, 2019 & 2027
4.2.1 Services
4.2.1.1 Services market, 2016 – 2027 (USD Million)
4.2.1.2 Therapeutic services
4.2.1.2.1 Therapeutic services market, 2016 – 2027 (USD Million)
4.2.1.2.2 Angioplasty
4.2.1.2.2.1 Angioplasty market, 2016 – 2027 (USD Million)
4.2.1.2.3 Stent Placement
4.2.1.2.3.1 Stent Placement market, 2016 – 2027 (USD Million)
4.2.1.2.4 Rotational atherectomy
4.2.1.2.4.1 Rotational atherectomy market, 2016 – 2027 (USD Million)
4.2.1.2.5 Thrombectomy
4.2.1.2.5.1 Thrombectomy market, 2016 – 2027 (USD Million)
4.2.1.2.6 Cardioversion
4.2.1.2.6.1 Cardioversion market, 2016 – 2027 (USD Million)
4.2.1.2.7 Transcatheter Aortic Valve Replacement (TAVR)
4.2.1.2.7.1 Transcatheter Aortic Valve Replacement (TAVR) market, 2016 – 2027 (USD Million)
4.2.1.2.8 Others
4.2.1.2.8.1 Others market, 2016 – 2027 (USD Million)
4.2.1.3 Diagnostic services
4.2.1.3.1 Diagnostic services market, 2016 – 2027 (USD Million)
4.2.1.3.2 Angiography
4.2.1.3.2.1 Angiography market, 2016 – 2027 (USD Million)
4.2.1.3.3 Coronary intravascular ultrasound
4.2.1.3.3.1 Coronary intravascular ultrasound market, 2016 – 2027 (USD Million)
4.2.1.3.4 Cardiac catheterization
4.2.1.3.4.1 Cardiac catheterization market, 2016 – 2027 (USD Million)
4.2.1.3.5 ECG/EKG
4.2.1.3.5.1 ECG/EKG market, 2016 – 2027 (USD Million)
4.2.1.3.6 Fractional Flow Reserve (FFR)
4.2.1.3.6.1 Fractional Flow Reserve (FFR) market, 2016 – 2027 (USD Million)
4.2.1.3.7 Others
4.2.1.3.7.1 Others market, 2016 – 2027 (USD Million)
4.2.2 Equipment
4.2.2.1 Equipment market, 2016 – 2027 (USD Million)
Chapter 5 U.S. Cath Labs Market: Facility Type Estimates & Trend Analysis
5.1 Segment Dashboard
5.2 U.S. Cath Labs Market: Facility Type Movement Analysis, USD Million, 2019 & 2027
5.2.1 Independent Labs
5.2.1.1 Independent Labs market, 2016 – 2027 (USD Million)
5.2.2 Hospital based labs
5.2.2.1 Hospital based labs market, 2016 – 2027 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players)
6.2 Recent Developments & Impact Analysis, by Key Market Participants
6.2.1 Company market position analysis (Overall revenue, market presence, product portfolio, geographic presence, strategic initiatives)
6.3 Company Profiles
6.3.1 GE Healthcare
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.1.5 SWOT analysis
6.3.2 Siemens Healthineers
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.2.5 SWOT analysis
6.3.3 Koninklijke Philips N.V
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.3.5 SWOT analysis
6.3.4 Shimadzu Corporation
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.4.5 SWOT analysis
6.3.5 Johnson & Johnson
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.5.5 SWOT analysis
6.3.6 Medtronic PLC
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.6.5 SWOT analysis
6.3.7 B. Braun Melsungen AG
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.7.5 SWOT analysis
Chapter 7 Recommendations
Chapter 8 Research Methodology & Scope
8.1 Research Methodology
8.1.1 Information Procurement
8.1.1.1 Purchased database:
8.1.1.2 GVR’s internal database
8.1.2 Primary Research
8.2 Research Scope and Assumptions
8.3 List to Data Sources

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of Abbreviation


List of Figures

Fig. 1 U.S. Cath labs market segmentation
Fig. 2 Market outlook, 2019 (USD Million)
Fig. 3 U.S. Cath labs market trends & outlook
Fig. 4 Market driver relevance analysis (Current & future impact)
Fig. 5 Market restraint relevance analysis (Current & future impact)
Fig. 6 Penetration & growth prospect mapping
Fig. 7 U.S. Cath labs component market share analysis, 2019 & 2027 (USD Million)
Fig. 8 U.S Cath labs component market: Segment dashboard
Fig. 9 Services market, 2016 - 2027 (USD Million)
Fig. 10 Therapeutic services market, 2016 - 2027 (USD Million)
Fig. 11 Angioplasty market, 2016 - 2027 (USD Million)
Fig. 12 Stent placement market, 2016 - 2027 (USD Million)
Fig. 13 Rotational atherectomy market, 2016 - 2027 (USD Million)
Fig. 14 Thrombectomy market, 2016 - 2027 (USD Million)
Fig. 15 Cardioversion market, 2016 - 2027 (USD Million)
Fig. 16 TAVR market, 2016 - 2027 (USD Million)
Fig. 17 Others market, 2016 - 2027 (USD Million)
Fig. 18 Diagnostic services market, 2016 - 2027 (USD Million)
Fig. 19 Angiography market, 2016 - 2027 (USD Million)
Fig. 20 Coronary intravascular ultrasound market, 2016 - 2027 (USD Million)
Fig. 21 Cardiac catheterization atherectomy market, 2016 - 2027 (USD Million)
Fig. 22 ECG/EKG market, 2016 - 2027 (USD Million)
Fig. 23 Fractional flow reserve market, 2016 - 2027 (USD Million)
Fig. 24 Others market, 2016 - 2027 (USD Million)
Fig. 25 Equipment market, 2016 - 2027 (USD Million)
Fig. 26 U.S. Cath labs facility type market share analysis, 2019 & 2027 (USD Million)
Fig. 27 U.S Cath labs facility type market: Segment dashboard
Fig. 28 Independent labs market, 2016 - 2027 (USD Million)
Fig. 29 Hospital-based labs market, 2016 - 2027 (USD Million)
Fig. 30 Impact analysis by key market participants
Fig. 31 Strategy framework/Competition categorization
Fig. 32 Company market position analysis (Overall revenue, market presence, product portfolio, geographic presence, strategic Initiatives)
Fig. 33 Market research process
Fig. 34 Information procurement
Fig. 35 Primary research pattern
Fig. 36 Market research approaches
Fig. 37 Value-chain-based sizing & forecasting
Fig. 38 QFD modeling for market share assessment
Fig. 39 Market formulation & validation

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[キャスラボのアメリカ市場2020-2027:コンポーネント別(サービス(治療サービス、診断サービス)、機器)、施設種類別(個人研究所、病院系研究所)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆